FDA establishes new center to streamline new drug development using RWD/RWE
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesCBERCDERPharmaceuticalsRegulatory Intelligence/PolicyRWE/RWDUnited StatesUS Food and Drug Administration (FDA)